AQB Key Statistics, Chart & Performance
The current stock price of AQB is 1.02 USD. In the past month the price increased by 6.67%. In the past year, price increased by 46.13%.
AQB Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.34 | 406.46B | ||
| AMGN | AMGEN INC | 15.22 | 179.28B | ||
| GILD | GILEAD SCIENCES INC | 15.23 | 154.71B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 26.66 | 117.45B | ||
| REGN | REGENERON PHARMACEUTICALS | 17.44 | 82.50B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 785.47 | 52.92B | ||
| INSM | INSMED INC | N/A | 37.94B | ||
| NTRA | NATERA INC | N/A | 32.26B | ||
| BIIB | BIOGEN INC | 10.58 | 25.98B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.22 | 21.84B | ||
| INCY | INCYTE CORP | 15.59 | 19.65B | ||
| EXAS | EXACT SCIENCES CORP | N/A | 19.27B |
Related stock screener links
About AQB
Company Profile
AquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. The company is headquartered in Harvard, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2017-01-09. The Company’s technology advances in fish breeding, genetics, and health and nutrition. The company locates its land-based recirculating aquaculture system farms close to key consumption markets, which are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. Its land-based farms utilize Recirculating Aquaculture Systems, which are designed to prevent disease and include multiple levels of fish containment designed to protect wild fish populations. Recirculating Aquaculture Systems facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens which might enter the system.
Company Info
AQUABOUNTY TECHNOLOGIES
233 Ayer Road Suite 4, Suite 4
Harvard MASSACHUSETTS 01754 US
CEO: Sylvia A. Wulf
Employees: 4
Phone: 19786486000
AQUABOUNTY TECHNOLOGIES / AQB FAQ
Can you describe the business of AQUABOUNTY TECHNOLOGIES?
AquaBounty Technologies, Inc. engages in the provision of land-based aquaculture services. The company is headquartered in Harvard, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2017-01-09. The Company’s technology advances in fish breeding, genetics, and health and nutrition. The company locates its land-based recirculating aquaculture system farms close to key consumption markets, which are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. Its land-based farms utilize Recirculating Aquaculture Systems, which are designed to prevent disease and include multiple levels of fish containment designed to protect wild fish populations. Recirculating Aquaculture Systems facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens which might enter the system.
What is the current price of AQB stock?
The current stock price of AQB is 1.02 USD. The price increased by 20.38% in the last trading session.
Does AQB stock pay dividends?
AQB does not pay a dividend.
How is the ChartMill rating for AQUABOUNTY TECHNOLOGIES?
AQB has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What sector and industry does AQUABOUNTY TECHNOLOGIES belong to?
AQUABOUNTY TECHNOLOGIES (AQB) operates in the Health Care sector and the Biotechnology industry.
What is the market capitalization of AQB stock?
AQUABOUNTY TECHNOLOGIES (AQB) has a market capitalization of 3.96M USD. This makes AQB a Nano Cap stock.
What is the Short Interest ratio of AQUABOUNTY TECHNOLOGIES (AQB) stock?
The outstanding short interest for AQUABOUNTY TECHNOLOGIES (AQB) is 0.61% of its float.
AQB Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to AQB. When comparing the yearly performance of all stocks, AQB turns out to be only a medium performer in the overall market: it outperformed 43.91% of all stocks.
AQB Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AQB. AQB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
AQB Financial Highlights
Over the last trailing twelve months AQB reported a non-GAAP Earnings per Share(EPS) of -22.82. The EPS decreased by -19.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -365.49% | ||
| ROE | -721.82% | ||
| Debt/Equity | 0 |
AQB Forecast & Estimates
For the next year, analysts expect an EPS growth of 86.82% and a revenue growth 43.65% for AQB